Your browser doesn't support javascript.
loading
Endoplasmic reticulum-targeting doxorubicin: a new tool effective against doxorubicin-resistant osteosarcoma.
Buondonno, Ilaria; Gazzano, Elena; Tavanti, Elisa; Chegaev, Konstantin; Kopecka, Joanna; Fanelli, Marilù; Rolando, Barbara; Fruttero, Roberta; Gasco, Alberto; Hattinger, Claudia; Serra, Massimo; Riganti, Chiara.
Afiliación
  • Buondonno I; Department of Oncology, University of Torino, Via Santena 5/bis, 10126, Torino, Italy.
  • Gazzano E; Department of Oncology, University of Torino, Via Santena 5/bis, 10126, Torino, Italy.
  • Tavanti E; Laboratory of Experimental Oncology, Pharmacogenomics and Pharmacogenetics Research Unit, Orthopaedic Rizzoli Institute I.R.C.C.S, Bologna, Italy.
  • Chegaev K; Department of Drug Science and Technology, University of Torino, Torino, Italy.
  • Kopecka J; Department of Oncology, University of Torino, Via Santena 5/bis, 10126, Torino, Italy.
  • Fanelli M; Laboratory of Experimental Oncology, Pharmacogenomics and Pharmacogenetics Research Unit, Orthopaedic Rizzoli Institute I.R.C.C.S, Bologna, Italy.
  • Rolando B; Department of Drug Science and Technology, University of Torino, Torino, Italy.
  • Fruttero R; Department of Drug Science and Technology, University of Torino, Torino, Italy.
  • Gasco A; Department of Drug Science and Technology, University of Torino, Torino, Italy.
  • Hattinger C; Laboratory of Experimental Oncology, Pharmacogenomics and Pharmacogenetics Research Unit, Orthopaedic Rizzoli Institute I.R.C.C.S, Bologna, Italy.
  • Serra M; Laboratory of Experimental Oncology, Pharmacogenomics and Pharmacogenetics Research Unit, Orthopaedic Rizzoli Institute I.R.C.C.S, Bologna, Italy.
  • Riganti C; Department of Oncology, University of Torino, Via Santena 5/bis, 10126, Torino, Italy. chiara.riganti@unito.it.
Cell Mol Life Sci ; 76(3): 609-625, 2019 Feb.
Article en En | MEDLINE | ID: mdl-30430199

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Doxorrubicina / Osteosarcoma / Sistemas de Liberación de Medicamentos / Resistencia a Antineoplásicos / Retículo Endoplásmico Límite: Humans Idioma: En Revista: Cell Mol Life Sci Asunto de la revista: BIOLOGIA MOLECULAR Año: 2019 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Doxorrubicina / Osteosarcoma / Sistemas de Liberación de Medicamentos / Resistencia a Antineoplásicos / Retículo Endoplásmico Límite: Humans Idioma: En Revista: Cell Mol Life Sci Asunto de la revista: BIOLOGIA MOLECULAR Año: 2019 Tipo del documento: Article País de afiliación: Italia
...